课题基金 / 基金详情

NEW GENERATION OF POLYANHYDRIDES

NEW GENERATION OF POLYANHYDRIDES
新一代聚酐
批准号:
2748616
负责人:
DAVID A PUTNAM
金额:
$2.92万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
未结题
起止时间:
1998-08-01 至

项目摘要

项目成果

DAVID A PUTNAM的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Internal long hone fracture fixation using bioerodible polymers based on polylactic acid, polyglycolic acid or poly-p-dioxanon have failed to provide adequate results due to either poor biocompatility, lack of adequate mechanical strength or unpredictable degradation concerns. For these reasons the first poly(anhydride-co-imides) were synthesized. However, these poly(anhydride-co-imides) contained imide ring systems that weren't biomolecule based which may also raise biocompatibility concerns. Therefore, the specific aims of this proposal are to: 1) synthesize a new generation of poly(anhydride-co-imide) polymers containing physiologically based ring systems, such as the pyrimidine rings of uracil and thymine, 2) to determine the mechanical properties of the polymers, 3) to study the degradation characteristics of the polymers in solution and in the solid state, and 4) to determine the initial biocompatibility characteristics of these polymers in vitro. The synthesis of the monomers will be conducted using pyrimidine chemistry techniques and polymerizations will be carried out using variations of techniques previously developed in Dr. Langer's laboratory. The polymer mechanical properties will be characterized by comprehensive strength, tensile strength, fracture strain, elastic moduli and tension-compression fatigue testing. The stability and degradation of the polymers will be determined by gel permeation chromatography. The biocompatibility of the polymers will be determined using bovine aortic endothelial cells and human fibroblast cells in culture. Bioerodible polymers for fracture fixation have an additional advantage over traditional metallic implants in that they could simultaneously deliver drugs to the fracture site.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Co-Presentation and Delivery of TLR Agonist Combinations with Subunit Antigens to Pathogen-Match the Immune Response
  • 批准号:
    10464899
  • 项目类别:
  • 资助金额:
    $58.29万
  • 财政年份:
    2018
  • 负责人:
    DAVID A PUTNAM
  • 依托单位:
Co-Presentation and Delivery of TLR Agonist Combinations with Subunit Antigens to Pathogen-Match the Immune Response
  • 批准号:
    9980271
  • 项目类别:
  • 资助金额:
    $58.16万
  • 财政年份:
    2018
  • 负责人:
    DAVID A PUTNAM
  • 依托单位:
Co-Presentation and Delivery of TLR Agonist Combinations with Subunit Antigens to Pathogen-Match the Immune Response
  • 批准号:
    10225567
  • 项目类别:
  • 资助金额:
    $58.23万
  • 财政年份:
    2018
  • 负责人:
    DAVID A PUTNAM
  • 依托单位:
Co-Presentation and Delivery of TLR Agonist Combinations with Subunit Antigens to Pathogen-Match the Immune Response
  • 批准号:
    9763442
  • 项目类别:
  • 资助金额:
    $58.1万
  • 财政年份:
    2018
  • 负责人:
    DAVID A PUTNAM
  • 依托单位: